The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of O'heeron Pete since 2019.
This trader's CIK number is 1569334.
At the time of last reporting, O'heeron Pete was the CHIEF EXECUTIVE OFFICER of Fibrobiologics, Inc.. (stock ticker symbol FBLG).
Also see all insider trading activities at Fibrobiologics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | FBLG | 51,500 | $19,522 | 0 | $0 | 0 | $0 |
| 2024 | FBLG | 8,500 | $16,269 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | LBSR | 6,271,388 | $513,373 | 0 | $0 | 0 | $0 |
| 2023 | LBSR | 24,266,854 | $1,074,889 | 0 | $0 | 0 | $0 |
| 2022 | LBSR | 1,096,299 | $273,430 | 0 | $0 | 0 | $0 |
| 2021 | LBSR | 101,599 | $65,008 | 0 | $0 | 0 | $0 |
| 2017 | LBSR | 904,126 | $10,615 | 0 | $0 | 0 | $0 |
1. Fibrobiologics, Inc. (FBLG)
2. Liberty Star Uranium & Metals Corp. (LBSR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-03 | FBLG | Buy | 18,200 | .41 | 7,371 |
| 2026-03-04 | FBLG | Buy | 15,872 | .38 | 5,999 |
| 2026-03-02 | FBLG | Buy | 17,428 | .35 | 6,152 |
| 2024-08-12 | FBLG | Buy | 8,500 | 1.91 | 16,269 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-27 | LBSR | Buy | 3,190,718 | .07 | 236,113 |
| 2025-03-04 | LBSR | Buy | 3,080,670 | .09 | 277,260 |
| 2023-10-12 | LBSR | Buy | 19,500,000 | .04 | 780,000 |
| 2023-08-29 | LBSR | Buy | 954,707 | .05 | 51,554 |
| 2023-08-11 | LBSR | Buy | 200,200 | .34 | 68,068 |
| 2023-07-17 | LBSR | Buy | 1,190,845 | .04 | 50,015 |
| 2023-07-12 | LBSR | Buy | 1,410,652 | .05 | 64,889 |
| 2023-06-12 | LBSR | Buy | 464,943 | .05 | 25,106 |
| 2023-06-12 | LBSR | Buy | 464,943 | .05 | 25,106 |
| 2023-01-30 | LBSR | Buy | 80,564 | .13 | 10,151 |
| 2022-12-02 | LBSR | Buy | 63,107 | .10 | 6,500 |
| 2022-10-03 | LBSR | Buy | 74,000 | .15 | 11,100 |
| 2022-08-12 | LBSR] | Buy | 26,738 | .19 | 5,000 |
| 2022-01-05 | LBSR | Buy | 932,454 | .27 | 250,830 |
| 2021-10-01 | LBSR | Buy | 60,887 | .57 | 35,010 |
| 2021-10-04 | LBSR | Buy | 25,986 | .58 | 14,993 |
| 2021-04-01 | LBSR | Buy | 14,726 | 1.02 | 15,005 |
| 2017-10-13 | LBSR | Buy | 226,619 | .00 | 453 |
| 2014-08-12 | LBSR | Buy | 677,507 | .01 | 10,162 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'heeron Pete (CHIEF EXECUTIVE OFFICER of Fibrobiologics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.